Medical News

RSS

VuCOMP receives PMA for M-Vu CAD system

VuCOMP, Inc., developer of computer-aided detection (CAD) systems for automatic analysis of medical imagery, is pleased to announce premarket approval (PMA) of M-Vu, a cutting-edge CAD system for film mammography.

3 Feb 2012

Newly divorced middle aged women more vulnerable to contract HIV and other STDs

Newly divorced middle aged women are more vulnerable to contract HIV and other sexually transmitted diseases, according to Christopher Coleman, PhD, MPH, RN, associate professor at the University of Pennsylvania School of Nursing, because they tend to let their guard down with new sexual partners and avoid using protection since they are unafraid of getting pregnant.

3 Feb 2012

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.

3 Feb 2012

Study to understand links between premature birth and maths disability in children

Around 160 school children from London and the Midlands are taking part in a pioneering research project, funded by Action Medical Research, to try to understand the links between being born very prematurely and struggling with mathematics.

3 Feb 2012

Majority of geriatric patients in German rehabilitation hospital have vitamin D deficiency

The great majority of geriatric patients in a German rehabilitation hospital were found to have vitamin D deficiency. Stefan Schilling presents his study results in this week's issue of Deutsches Ärzteblatt International.

3 Feb 2012

Medical Properties Trust prices $200 million public offering

Medical Properties Trust, Inc. announced today that the previously announced public offering of $200 million aggregate principal amount of senior notes due 2022 by its operating partnership, MPT Operating Partnership, L.P., a Delaware limited partnership, and MPT Finance Corporation, a Delaware corporation and wholly owned subsidiary of the Operating Partnership, priced today with a coupon of 6.375%, at an issue price of 100%.

3 Feb 2012

Should smacking of children be banned?

Dr Gervase Chaney, the head of The Royal Australasian College of Physicians' Pediatric & Child Health Division, said it was no longer OK for mums and dads to argue “that it never did us any harm” and called on colleagues to stand up for children's rights. Professor Frank Oberklaid, a pediatrician from Melbourne's Royal Children's Hospital, said Australia was lagging behind other countries in outlawing smacking which, in some cases, could lead to abuse and even death.

3 Feb 2012

Worldwide malaria death figures - a gross underestimate, finds latest research

According to latest research malaria kills twice as many people every year as formerly believed, taking 1.2 million lives and causing the deaths not only of babies but also older children and adults.

3 Feb 2012

Sleep disorders cost the economy billions

New figures reveal that sleep disorders are costing the Australian economy more than $5.1 billion each year. The staggering amount covers health costs and loss of productivity for the more than 1.5 million workers suffering from sleep disorders including sleep apnea and insomnia.

3 Feb 2012

Addiction could be a legacy from parents: Study

Researchers have found that like other inherited traits – addiction could be a legacy from parents. A child of drug-addicted parents is eight times more likely to become an addict than a child growing up in a drug-free home. However in families whose very brains seem primed for addiction, some children still go on to lead productive lives free of drugs, according to new research.

3 Feb 2012

New MRSA ‘superbug’ worries experts

A deadly mutant bug could be spreading among the public warn experts. The deadly strain of Methicillin-Resistant Staphylococcus Aureus (MRSA) called USA300 passes easily through skin-to-skin contact. It can also survive on surfaces and so has the potential to be picked up on crowded buses and tubes. The first cases were seen in the US but cases are now being reported in the community and not just hospitals in Britain.

3 Feb 2012

General anesthesia in infancy linked to ADHD

New research suggests that infants who undergo surgical procedures requiring general anesthesia in their first two years of life may be at increased risk of developing attention deficit hyperactivity disorder (ADHD) as they grow older.

3 Feb 2012

Is sugar as bad as alcohol and tobacco?

According to US health experts, sugar is as damaging and addictive as alcohol or tobacco and should be regulated. The University of California team suggests new policies such as taxes are needed to control soaring consumption of sugar and sweeteners. Prof Robert Lustig argues in the opinion piece called “The Toxic Truth About Sugar” in journal Nature for major shifts in public policy.

3 Feb 2012

Setting the scene for the Supreme Court’s consideration of the health law

Two state attorneys general will face off at the National Press Club on the constitutionality of the health overhaul. In other news, a Mississippi district court judge has agreed to hear a different legal challenge to the measure.

3 Feb 2012

Urine-based biomarkers may lead to development of test for high-risk prostate cancer

Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance approach to manage their disease.

3 Feb 2012

OptiNose to initiate novel intranasal technology Phase III trials in acute migraine

OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration (FDA) in December, 2011. The FDA has completed its review and has notified OptiNose that the studies under this IND may proceed. The Company will initiate Phase III trials in adults with acute migraine with or without aura utilizing its novel intranasal technology.

3 Feb 2012